Production of Secretory Leucocyte Protease Inhibitor (SLPI) in Human Pancreatic β-Cells
Secretory leucocyte protease inhibitor (SLPI) is a potent inhibitor of granulocyte elastase and cathepsin G, and also an inhibitor of pancreatic enzymes like trypsin, chymotrypsin and pancreatic elastase. SLPI has also been shown to inhibit HIV-1 infections by blocking viral DNA synthesis. Since SLP...
Saved in:
Main Authors: | Max Nyström, Magnus Bergenfeldt, Irena Ljungcrantz, Èsa Lindeheim, Kjell Ohlsson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1999-01-01
|
Series: | Mediators of Inflammation |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09629359990478 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release
by: U. Westin, et al.
Published: (1998-01-01) -
Prospects of betulin application in broiler farming
by: M. V. Novikova, et al.
Published: (2021-01-01) -
Novel distribution of the secretory leucocyte proteinase inhibitor in kidney
by: Sophie Ohlsson, et al.
Published: (2001-01-01) -
Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa
by: Max Nyström, et al.
Published: (2001-01-01) -
The presence of elafin, SLPI, IL1-RA and STNFα RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation
by: U. Westin, et al.
Published: (2002-01-01)